Home/Recalls/FDA-D-0607-2026
FDA DrugsClass II

Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules...

Published: June 17, 2026Recall ID: D-0607-2026Category: drugsCountry: US

Reason for Recall / Hazard

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Product Description & Identification

Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49.

Additional Source Details

FieldValue
CityPrinceton
StateNJ
Openfda › Nui › 1N0000175576
Openfda › Nui › 2N0000175450
Openfda › UniiQ3OKS62Q6X
Openfda › RouteRESPIRATORY (INHALATION)
Openfda › Rxcui › 1252559
Openfda › Rxcui › 2349094
Openfda › Rxcui › 3351109
Openfda › Spl idc5265800-f7ea-4258-8555-5465104858a0
Openfda › Brand nameBUDESONIDE
Openfda › Spl set ida39fbcfc-3ffd-44bd-b882-01f8e1844213
Openfda › Package ndc › 147335-631-48
Openfda › Package ndc › 247335-631-49
Openfda › Package ndc › 347335-632-48
Openfda › Package ndc › 447335-632-49
Openfda › Package ndc › 547335-633-48
Openfda › Package ndc › 647335-633-49
Openfda › Product ndc › 147335-631
Openfda › Product ndc › 247335-632
Openfda › Product ndc › 347335-633
Openfda › Generic nameBUDESONIDE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameBUDESONIDE
Openfda › Pharm class epcCorticosteroid [EPC]
Openfda › Pharm class moaCorticosteroid Hormone Receptor Agonists [MoA]
Openfda › Manufacturer nameSun Pharmaceutical Industries, Inc.
Openfda › Application numberANDA211922
Openfda › Is original packagertrue
Event id99113
Address 12 Independence Way
Address 2N/A
Code infoLot #: BAG0074A, Exp. Date: 1/31/2027.
Postal code08540-6620
Report date20260617
Product typeDrugs
Product quantityN/A
Reason for recallPresence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260529
Initial firm notificationLetter
Center classification date20260618

Overview

  • Recalling FirmSUN PHARMACEUTICAL INDUSTRIES INC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States
Official Agency Alert